至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Subcutaneous Immunization with Fusion Protein DnaJ-ΔA146Ply without Additional Adjuvants Induces both Humoral and Cellular Immunity against Pneumococcal Infection Partially Depending on TLR4.

Front Immunol.. 2017-06; 
Su Y,Li D,Xing Y,Wang H,Wang J,Yuan J,Wang X,Cui F,Yin Y,Zhang X.
Products/Services Used Details Operation
ToxinSensor Single Test Kit ... Column fractions were analyzed by 10% SDS-PAGE. Proteins were dialyzed against PBS (phosphate-buffered saline) to remove imidazole. Lipopolysaccharides (LPSs) were removed from protein solutions using the Toxin Eraser Endotoxin Kit (Genscript, Piscataway, NJ, USA). ... Get A Quote

摘要

Subunit vaccines that are poorly immunogenic are often combined with adjuvants for immunization. Our previous research identified a pneumolysin variant (ΔA146Ply), a Toll-like receptor 4 agonist, that was an effective adjuvant in the protection of fusion protein DnaJ-ΔA146Ply against mucosal Streptococcus pneumoniae infections. For pneumococcal vaccines, World Health Organization recommend injection as a regular vaccination approach. Subcutaneous immunization is a common and effective method of injection, so we explored the immunity mechanism of subcutaneous immunization with DnaJ-ΔA146Ply. We found that mice immunized subcutaneously with fusion proteins ΔA146Ply-DnaJ and DnaJ-ΔA146Ply produced a higher an... More

关键词

DnaJ-ΔA146Ply; Streptococcus pneumoniae; TLR4; adjuvant; immune response